OPTUS Pharmaceutical Co., Ltd. engages in the manufacture and sale of ophthalmic products. Its products include artificial tears, eye drops, antibiotic ophthalmic solutions, and ethyl chloride spray. The company was founded on July 27, 2010 and is headquartered in Cheongju-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company